The Genetics Company Inc. enters distributorship agreement with Stratech Scientific Ltd.
Sharon Young, Director at Stratech Scientific Ltd. commented: “The Genetics Company's high quality research and diagnosis products will enable us to participate in and further develop the emerging field of neurodegenerative diseases in the UK and Ireland, especially in the areas of academic and industrial research as well as for in vitro diagnosis”.
Dr. Matyas Vegh, CEO at The Genetics Company added: “With Stratech we are pleased to have found the ideal partner to make our products available to customers in the UK and Ireland. This cooperation enables us to cover a highly attractive research and health care market in Europe".
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.